BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22471468)

  • 1. Prognostic significance of the metastatic lymph node ratio in T3 gastric cancer patients undergoing total gastrectomy.
    Feng J; Wu YF; Xu HM; Wang SB; Chen JQ
    Asian Pac J Cancer Prev; 2011; 12(12):3289-92. PubMed ID: 22471468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
    Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
    World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
    Hou Y; Wang X; Chen J
    World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
    Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
    Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of metastatic lymph nodes ratio in patients with T2-T3 stage gastric cancer].
    Feng RH; Zhu ZG; Yan M; Chen J; Xiang M; Yin HR; Lin YZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):431-5. PubMed ID: 17851782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.
    Espín F; Bianchi A; Llorca S; Feliu J; Palomera E; García O; Remon J; Suñol X
    Eur J Surg Oncol; 2012 Jun; 38(6):497-502. PubMed ID: 22445061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma.
    Spolverato G; Ejaz A; Kim Y; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Votanopoulos K; Acher AW; Jin LX; Hawkins WG; Schmidt C; Kooby DA; Worhunsky D; Saunders N; Cho CS; Levine EA; Maithel SK; Pawlik TM
    Ann Surg; 2015 Dec; 262(6):991-8. PubMed ID: 25563867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
    Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
    Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis.
    Son T; Hyung WJ; Kim JW; Kim HI; An JY; Cheong JH; Choi SH; Noh SH
    Ann Surg Oncol; 2014 Mar; 21(3):899-907. PubMed ID: 24276641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients.
    Yamashita H; Deng J; Liang H; Seto Y
    Surgery; 2017 Jun; 161(6):1588-1596. PubMed ID: 28111043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenectomy in patients with gastric cancer. A critical review.
    Nitti D; Marchet A; Olivieri M; Ambrosi A; Mencarelli R; Farinati F; Belluco C; Lise M
    Suppl Tumori; 2003; 2(5):S35-8. PubMed ID: 12914388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma].
    Yu JX; Wu YL; Yang LT
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):922-5. PubMed ID: 16029534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
    He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
    Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma.
    Kato M; Saji S; Kawaguchi Y; Kunieda K; Sugiyama Y; Takagi Y; Hiraoka T; Kumazawa I; Adachi T
    Hepatogastroenterology; 1999; 46(30):3281-6. PubMed ID: 10626202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features and prognostic impact of splenic hilar lymph node metastasis in proximal gastric carcinoma.
    Jeong O; Jung MR; Ryu SY
    Eur J Surg Oncol; 2019 Mar; 45(3):432-438. PubMed ID: 30389304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
    Pan Y; Liang H; Xue Q; Zhang RP; Cui QH; Liu N; Wang BG
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):376-80. PubMed ID: 18953840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.